Cargando…
A hybrid nanopharmaceutical for specific-amplifying oxidative stress to initiate a cascade of catalytic therapy for pancreatic cancer
BACKGROUND: Oxidative stress (OS) induced by an imbalance of oxidants and antioxidants is an important aspect in anticancer therapy, however, as an adaptive response, excessive glutathione (GSH) in the tumor microenvironment (TME) acts as an antioxidant against high reactive oxygen species (ROS) lev...
Autores principales: | Liu, Fan, Xiang, Qinyanqiu, Luo, Yuanli, Luo, Ying, Luo, Wenpei, Xie, Qirong, Fan, Jingdong, Ran, Haitao, Wang, Zhigang, Sun, Yang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10207777/ https://www.ncbi.nlm.nih.gov/pubmed/37221521 http://dx.doi.org/10.1186/s12951-023-01932-0 |
Ejemplares similares
-
Nanopharmaceutics
por: Ali, Javed
Publicado: (2011) -
Trends in Nanopharmaceutical Patents
por: Antunes, Adelaide, et al.
Publicado: (2013) -
Nanopharmaceuticals (part 1): products on the market
por: Weissig, Volkmar, et al.
Publicado: (2014) -
Nanopharmaceuticals (part 2): products in the pipeline
por: Weissig, Volkmar, et al.
Publicado: (2015) -
Emerging Nanopharmaceuticals and Nanonutraceuticals in Cancer Management
por: Salama, Lavinia, et al.
Publicado: (2020)